World's Best Scientists 2026 revealed!
Angelo Paolo Dei Tos

Angelo Paolo Dei Tos

D-Index & Metrics

Medicine

D-Index
84
Citations
31485
World Ranking
14941
National Ranking
582

Angelo Paolo Dei Tos publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Angelo Paolo Dei Tos sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 412 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Angelo Paolo Dei Tos D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Angelo Paolo Dei Tos sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Angelo Paolo Dei Tos is affiliated with the University of Padua in Italy and has contributed extensively to the field of medical research, particularly within oncology and related disciplines. Their work spans over 665 publications in Medicine, with significant contributions to subfields including Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Rheumatology, and Surgery.

The scientist's research focuses on several key topics such as Sarcoma Diagnosis and Treatment, Vascular Tumors and Angiosarcomas, Lymphoma Diagnosis and Treatment, Cardiac Tumors and Thrombi, Bone Tumor Diagnosis and Treatments, Cancer Immunotherapy and Biomarkers, and Genetic Factors in Colorectal Cancer.

Notable recent papers authored or coauthored by Angelo Paolo Dei Tos include:

  • "The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives", 2020, published in Pathologica
  • "Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up", 2021, published in Annals of Oncology
  • "Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up", 2021, published in Annals of Oncology
  • "The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients", 2020, published in European Journal of Cancer
  • "Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial", 2020, published in The Lancet Oncology

Angelo Paolo Dei Tos collaborates frequently with several researchers, including:

  • Marta Sbaraglia
  • Matteo Fassan
  • Alessandro Gronchi
  • Silvia Stacchiotti
  • Paolo G. Casali

Their work is regularly published in several scientific journals and venues, with the most frequent being:

  • Frontiers in Oncology
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Journal of Clinical Oncology
  • Annals of Oncology
  • ESMO Open

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

    Winette T A Van Der Graaf;Jean Yves Blay;Sant P. Chawla;Dong Wan Kim

  • Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts

    Heikki Joensuu;Aki Vehtari;Jaakko Riihimäki;Toshirou Nishida

  • Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

    Ian Judson;Jaap Verweij;Hans Gelderblom;Jörg T Hartmann;Jörg T Hartmann

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Whole-genome landscape of pancreatic neuroendocrine tumours

    Aldo Scarpa;David K. Chang;Katia Nones;Katia Nones;Vincenzo Corbo

  • Rare cancers are not so rare: The rare cancer burden in Europe

    Gemma Gatta;Jan Maarten van der Zwan;Paolo G Casali;Sabine Siesling

  • twist is a potential oncogene that inhibits apoptosis

    Roberta Maestro;Angelo P. Dei Tos;Yasuo Hamamori;Svetlana Krasnokutsky

  • The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives

    Marta Sbaraglia;Elena Bellan;Angelo Paolo Dei Tos

  • Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Paolo G. Casali;Jean-Yves Blay;Alexia Bertuzzi;Stefan Bielack

  • Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

    Alessandro Gronchi;Stefano Ferrari;Vittorio Quagliuolo;Javier Martin Broto

  • Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.

    Andrew L Folpe;John R Goldblum;Brian P Rubin;Bahig M Shehata

  • Liposarcoma: New entities and evolving concepts

    Angelo P. Dei Tos

  • Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis

    Dario Callegaro;Rosalba Miceli;Sylvie Bonvalot;Peter Ferguson

  • Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.

    Sylvie Bonvalot;Alessandro Gronchi;Cécile Le Péchoux;Carol J. Swallow

  • The management of desmoid tumours : A joint global consensus-based guideline approach for adult and paediatric patients

    Ben Alman;Steven Attia;Christina Baumgarten;Charlotte Benson

  • Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test

    Manuel Zorzi;Ugo Fedeli;Elena Schievano;Emanuela Bovo

  • Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.

    Angelo P. Dei Tos;Claudio Doglioni;Sara Piccinin;Raf Sciot

  • Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions.

    Giuseppe Mastrangelo;Jean Michel Coindre;Françoise Ducimetière;Angelo Paolo Dei Tos

  • Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases.

    Thomas Mentzel;Angelo P. Dei Tos;Zoltan Sapi;Heinz Kutzner

Frequent Co-Authors

Paolo G. Casali
Paolo G. Casali University of Milan
Alessandro Gronchi
Alessandro Gronchi University of Milan
Silvia Stacchiotti
Silvia Stacchiotti University of Milan
Roberta Maestro
Roberta Maestro Centro di Riferimento Oncologico
Piero Picci
Piero Picci University of Bologna
Bruno Vincenzi
Bruno Vincenzi Università Campus Bio-Medico
Jean-Yves Blay
Jean-Yves Blay Claude Bernard University Lyon 1
Matteo Fassan
Matteo Fassan University of Padua
Silvana Pilotti
Silvana Pilotti University of Milan
Daniele Santini
Daniele Santini Università Campus Bio-Medico

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are several flexible, accessible pathways to begin or advance a healthcare career beyond traditional medical school. For those seeking a rapid entry point, fast track LPN programs online provide a way to quickly launch a career as a Licensed Practical Nurse, with many programs designed to be completed in under a year.

Nurses looking to specialize can consider the fastest post master's PMHNP programs. These accelerated psychiatric nurse practitioner degrees equip graduates to meet the growing need for mental health services in diverse clinical settings.

If you’re interested in healthcare leadership or administration, an online health management degree is a practical route. These programs focus on the skills required to oversee hospital departments, clinics, and healthcare systems.

For more advanced roles with greater responsibility, explore cheap MHA programs. Earning a Master’s in Healthcare Administration opens doors to executive and senior management positions, often with flexible and affordable online options.

Best Scientists Citing Angelo Paolo Dei Tos

Trending Scientists

Recently Published Articles